Chevy Chase Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,119
| Closed | -$66K | – | 776 |
|
|
2019
Q4 | $66K | Buy |
+1,119
| New | +$66K | ﹤0.01% | 778 |
|
|
2018
Q4 | – | Sell |
-5,539
| Closed | -$278K | – | 733 |
|
|
2018
Q3 | $278K | Buy |
5,539
+956
| +21% | +$48K | ﹤0.01% | 620 |
|
|
2018
Q2 | $231K | Hold |
4,583
| – | – | ﹤0.01% | 640 |
|
|
2018
Q1 | $224K | Buy |
+4,583
| New | +$224K | ﹤0.01% | 636 |
|
|
2017
Q2 | – | Sell |
-3,811
| Closed | -$201K | – | 661 |
|
|
2017
Q1 | $201K | Sell |
3,811
-375
| -9% | -$19.8K | ﹤0.01% | 635 |
|
|
2016
Q4 | $201K | Sell |
4,186
-736
| -15% | -$35.3K | ﹤0.01% | 648 |
|
|
2016
Q3 | $265K | Sell |
4,922
-109
| -2% | -$5.87K | ﹤0.01% | 604 |
|
|
2016
Q2 | $273K | Sell |
5,031
-1,307
| -21% | -$70.9K | ﹤0.01% | 605 |
|
|
2016
Q1 | $321K | Buy |
6,338
+587
| +10% | +$29.7K | ﹤0.01% | 599 |
|
|
2015
Q4 | $290K | Hold |
5,751
| – | – | ﹤0.01% | 613 |
|
|
2015
Q3 | $276K | Sell |
5,751
-1,571
| -21% | -$75.4K | ﹤0.01% | 612 |
|
|
2015
Q2 | $381K | Sell |
7,322
-640
| -8% | -$33.3K | ﹤0.01% | 596 |
|
|
2015
Q1 | $459K | Sell |
7,962
-299
| -4% | -$17.2K | ﹤0.01% | 599 |
|
|
2014
Q4 | $442K | Sell |
8,261
-4,122
| -33% | -$221K | ﹤0.01% | 608 |
|
|
2014
Q3 | $712K | Sell |
12,383
-2,342
| -16% | -$135K | ﹤0.01% | 589 |
|
|
2014
Q2 | $984K | Buy |
14,725
+2,222
| +18% | +$148K | 0.01% | 572 |
|
|
2014
Q1 | $835K | Buy |
12,503
+3,373
| +37% | +$225K | 0.01% | 577 |
|
|
2013
Q4 | $609K | Buy |
9,130
+2,387
| +35% | +$159K | ﹤0.01% | 584 |
|
|
2013
Q3 | $423K | Sell |
6,743
-160
| -2% | -$10K | ﹤0.01% | 597 |
|
|
2013
Q2 | $431K | Buy |
+6,903
| New | +$431K | ﹤0.01% | 597 |
|